Literature DB >> 1756258

Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.

N T Telang1, R Narayanan, H L Bradlow, M P Osborne.   

Abstract

Deregulated expression of the RAS oncogene is associated with tumorigenic transformation of mammary cells. Because of the complex, multiphasic nature of cancer progression, it is important to systematically identify the biomarkers specific for initiation, promotion, and progression of breast cancer. Mouse mammary epithelial cells (MMEC) were transfected with normal c-Ha-RAS proto oncogene (pH06N) and with mutant c-Ha-RAS oncogene (pH06T). The parental MMEC and the cloned transfectants pH06N1, pH06N2, pH06T1, and pH06T12 were evaluated for the acquisition of transformed characteristics by determining altered cellular metabolism of estradiol, increased ability for anchorage-independent growth, and ability to form tumors at the transplant site in athymic 'nude' mice. Persistent, functional integration of c-Ha-RAS was evidenced by the presence of a 1.2 kb c-Ha-RAS transcript in the four transfectants but not in MMEC. All the transfectants also exhibited a substantial increase in the binding of c-Ha-RAS p21 to [alpha-32P] GTP relative to MMEC (P less than 0.003). The relative extent of estradiol metabolism leading to the formation of 16 alpha-hydroxyestrone was increased (P less than 0.004) in all the four transfectants. These four transfectants also showed a 100-400 fold increase in colony forming efficiency in 0.33% agar, relative to MMEC (P less than 0.0009), and formed rapidly growing tumors within 3-5 weeks of transplantation. Our results demonstrate that i) persistent expression of normal and mutant c-Ha-RAS can bring about tumorigenic transformation of mouse mammary epithelial cells; and ii) alteration in estradiol metabolism and acquisition of anchorage-independent growth precede the emergence of a tumorigenic phenotype.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756258     DOI: 10.1007/bf01990031

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  34 in total

1.  Cellular ras protooncogene expression in human mammary explant cultures. A potential marker for chemical carcinogenesis.

Authors:  N T Telang; A Basu; M J Modak; M P Osborne
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 2.  Biological and molecular bases of mammary carcinogenesis.

Authors:  J Russo; I H Russo
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

3.  Malignant transformation of early passage rodent cells by a single mutated human oncogene.

Authors:  D A Spandidos; N M Wilkie
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

4.  In vitro biotransformation of estradiol by explant cultures of murine mammary tissues.

Authors:  N T Telang; H L Bradlow; H Kurihara; M P Osborne
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

5.  Activation of ras oncogenes preceding the onset of neoplasia.

Authors:  R Kumar; S Sukumar; M Barbacid
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

6.  Metabolic biotransformation of estradiol in human mammary explant cultures.

Authors:  N T Telang; D M Axelrod; H L Bradlow; M P Osborne
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

7.  Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology.

Authors:  J Fishman; C Martucci
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

8.  Oncogene activation in malignant transformation: a study of H-ras in human breast cancer.

Authors:  D A Spandidos
Journal:  Anticancer Res       Date:  1987 Sep-Oct       Impact factor: 2.480

9.  Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans.

Authors:  H L Bradlow; R J Hershcopf; C P Martucci; J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Transcriptional regulation of early growth response genes in FOS-expressing PC-12 cells.

Authors:  E Ito; N Nomura; R Narayanan
Journal:  Cell Regul       Date:  1990-03
View more
  9 in total

1.  Anti-proliferative and pro-apoptotic effects of rosemary and constituent terpenoids in a model for the HER-2-enriched molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

2.  Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification.

Authors:  Zhe Hou; Domenick J Falcone; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Carcinogenesis       Date:  2011-02-10       Impact factor: 4.944

Review 3.  Stem Cell Models for Cancer Therapy.

Authors:  Nitin Telang
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 4.  The Divergent Effects of Ovarian Steroid Hormones in the MCF-7 Model for Luminal A Breast Cancer: Mechanistic Leads for Therapy.

Authors:  Nitin T Telang
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

5.  Epithelial cell culture models for the prevention and therapy of clinical breast cancer (Review).

Authors:  Nitin Telang; Meena Katdare
Journal:  Oncol Lett       Date:  2012-01-10       Impact factor: 2.967

6.  Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.

Authors:  A Suto; H L Bradlow; G Y Wong; M P Osborne; N T Telang
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

Review 7.  Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.

Authors:  N T Telang; M Katdare; H L Bradlow; M P Osborne
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  Metabolomic profiling unravels DNA adducts in human breast that are formed from peroxidase mediated activation of estrogens to quinone methides.

Authors:  Nilesh W Gaikwad
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

Authors:  N T Telang; F Arcuri; O M Granata; H L Bradlow; M P Osborne; L Castagnetta
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.